Animal Molecular Breeding 2024, Vol.14, No.1, 106-118 http://animalscipublisher.com/index.php/amb 113 6 Technical Challenges and Limitations 6.1 Technical difficulties in gene editing and achieving stable modifications Gene editing in pigs for xenotransplantation presents several technical challenges. One of the primary difficulties is achieving stable and precise genetic modifications. The use of CRISPR-Cas9 and other gene-editing technologies has significantly advanced the field, allowing for the deletion of specific pig genes and the insertion of human genes to reduce immunogenicity and improve compatibility (Sykes and Sachs, 2019). However, ensuring that these modifications are stable across generations and do not negatively impact the pigs' health or reproductive capabilities remains a significant hurdle (Yue et al., 2020). Additionally, the complexity of editing multiple genes simultaneously to address various immunological and physiological barriers adds another layer of difficulty (Deng et al., 2022; Lei et al., 2022). 6.2 Potential off-target effects and genetic instability The potential for off-target effects is a major concern in gene editing. CRISPR-Cas9, while powerful, can introduce unintended mutations in the genome, which may lead to genetic instability or unforeseen health issues in the genetically modified pigs (Sykes and Sachs, 2019; Yue et al., 2020). These off-target effects can compromise the safety and efficacy of the xenotransplants. Moreover, the long-term stability of the genetic modifications is crucial, as any reversion or loss of the introduced traits could lead to graft rejection or other complications post-transplantation (Cooper et al., 2019). Continuous monitoring and advanced techniques to minimize off-target effects are essential to address these challenges. 6.3 Immunological challenges and unforeseen complications Despite significant progress, immunological challenges remain a major barrier to successful xenotransplantation. Genetically modified pigs are designed to reduce hyperacute rejection, acute humoral xenograft rejection, and other immune responses (Deng et al., 2022; Montgomery et al., 2022). However, the human immune system is highly complex, and unforeseen complications can arise. For instance, while modifications such as the knockout of the alpha-1,3-galactosyltransferase gene have shown promise in reducing hyperacute rejection, other immune responses, such as chronic rejection and cell-mediated damage, still pose significant risks (Coe et al., 2020). Additionally, the risk of transmitting porcine endogenous retroviruses (PERVs) to human recipients remains a concern, despite efforts to inactivate these viruses in the pig genome (Yue et al., 2020). The interplay between the modified pig tissues and the human immune system needs further investigation to fully understand and mitigate these risks. In conclusion, while genetic modifications in pigs offer a promising solution to the organ shortage crisis, several technical and immunological challenges must be addressed to ensure the safety and efficacy of xenotransplantation. Continuous advancements in gene-editing technologies and a deeper understanding of the immune responses involved are crucial for overcoming these barriers. 7 Future Directions and Perspectives 7.1 Emerging technologies and methods in genetic engineering Recent advancements in genetic engineering have significantly enhanced the potential for creating immune-compatible organs from pigs for human transplantation. The development of CRISPR-Cas9 technology has been particularly transformative, allowing for precise and efficient genetic modifications. This technology has enabled the deletion of pig genes responsible for the synthesis of xenoantigens and the insertion of human genes that regulate immune responses and coagulation processes (Sykes and Sachs, 2019). Additionally, the use of transposon technologies in combination with CRISPR-Cas9 has facilitated extensive genome engineering, including the inactivation of porcine endogenous retroviruses (PERVs) and the introduction of multiple human transgenes to improve immunological compatibility (Yue et al., 2020). These emerging technologies are paving the way for more sophisticated and effective genetic modifications in pigs, which are crucial for the success of xenotransplantation.
RkJQdWJsaXNoZXIy MjQ4ODY0NQ==